Data / New clinical trials / Carcinoma, Hepatocellular

Carcinoma, Hepatocellular trials: 553 new since Nov 2024

Name: New Carcinoma, Hepatocellular clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Carcinoma, Hepatocellular clinical trials: 553 rows for $27.65, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 18 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/carcinoma-hepatocellular, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

553 clinical studies in Carcinoma, Hepatocellular were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 87 have an industry sponsor and 454 are recruiting or about to. The newest, NCT07924943, was posted on November 9, 2026: Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation (SBRT) in Patients With Hepatocellular... (AIO-Studien-gGmbH).

The request: Every new Carcinoma, Hepatocellular clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

553New trials
87Industry sponsored
454Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 553, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07924943	Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation (SBRT) in Patients With Hepatocellular Carcinoma (HCC) Prior to...	AIO-Studien-gGmbH	Not applicable	Recruiting	HCC - Hepatocellular Carcinoma	44	Germany	clinicaltrials.gov
November 5, 2026	NCT07919717	NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC), Recurrent Hepatocellular Cancer	35	China	clinicaltrials.gov
November 4, 2026	NCT07917481	A Clinical Study Evaluating the Safety and Efficacy of Ivonescimab as Second-line Treatment in Patients With Advanced Hepatocellular...	MedSIR	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC), HCC - Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma (HCC)	44		clinicaltrials.gov
November 4, 2026	NCT07916376	Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response	UNC Lineberger Comprehensive Cancer Center	Not applicable	Not yet recruiting	Hepatocellular Carcinoma, Liver Cancer	12	United States	clinicaltrials.gov
November 3, 2026	NCT07911683	Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma	BeOne Medicines	Phase 2	Not yet recruiting	Hepatocellular Cancer, Liver Cancer, Hepatocellular Carcinoma	100		clinicaltrials.gov
October 29, 2026	NCT07904494	Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular...	Assiut University	Observational	Not yet recruiting	Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular...	294	Egypt	clinicaltrials.gov
October 26, 2026	NCT07895732	Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma	University Health Network, Toronto	Phase 3	Not yet recruiting	Hepatocellular Carcinoma (HCC)	60	Canada	clinicaltrials.gov
October 26, 2026	NCT07895342	Overcoming Immunotherapy Resistance in Hepatocellular Carcinoma	Radboud University Medical Center	Not applicable	Not yet recruiting	Hepatocellular Carcinoma Non-Resectable	16	Netherlands	clinicaltrials.gov
October 21, 2026	NCT07884877	PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer	Samsung Medical Center	Phase 2	Recruiting	Hepatocellular Carcinoma (HCC), Radiotherapy-Induced Immune Priming, Immunotherapy	38	South Korea	clinicaltrials.gov
October 20, 2026	NCT07882056	SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizumab for Hepatocellular Carcinoma	Peking University Cancer Hospital & Institute	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	33	China	clinicaltrials.gov
October 19, 2026	NCT07880106	Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Observational	Not yet recruiting	Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer	2,000	China	clinicaltrials.gov
October 16, 2026	NCT07878689	Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	Phase 1/2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	36	United States	clinicaltrials.gov
October 16, 2026	NCT07877220	Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration	M.D. Anderson Cancer Center	Not applicable	Not yet recruiting	Liver Tumors	200	United States	clinicaltrials.gov
October 13, 2026	NCT07872319	Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort.	Hospital Universitario La Paz	Observational	Completed	Hepatocellular Carcinoma (HCC)	417	Spain	clinicaltrials.gov
October 9, 2026	NCT07867522	Prevention of Bile Leakage After Liver Resection in Children	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Not applicable	Recruiting	Postoperative Bile Leak, Focal Liver Lesions	12	Russia	clinicaltrials.gov
October 8, 2026	NCT07866612	Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma	West China Hospital	Not applicable	Not yet recruiting	Hepatocellular Carcinoma	60	China	clinicaltrials.gov
October 7, 2026	NCT07863258	STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma	Universitaire Ziekenhuizen KU Leuven	Observational	Recruiting	Hepatocellular Carcinoma (HCC)	280	Belgium	clinicaltrials.gov
October 6, 2026	NCT07861425	Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With Advanced HCC Who Have Failed or Progressed on Standard...	Acepodia Biotech, Inc.	Phase 1	Not yet recruiting	Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Metastatic, Hepatocellular Carcinoma Non-Resectable	70	China	clinicaltrials.gov
September 30, 2026	NCT07850882	A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for...	Jie Yuan，MD	Observational	Recruiting	Colorectal Cancer (CRC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC)	30	China	clinicaltrials.gov
September 30, 2026	NCT07849660	Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)	Eisai Inc.	Observational	Active not recruiting	Carcinoma, Hepatocellular	170	United States	clinicaltrials.gov
September 30, 2026	NCT07848750	InstaSure™ Non-Invasive Finger-Press Test for Hepatocellular Carcinoma	Beijing Municipal Administration of Hospitals	Observational	Recruiting	Hepatocellular Carcinoma	40	China	clinicaltrials.gov
September 28, 2026	NCT07845266	Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable...	Beijing Gene Key Life Technology Co., Ltd	Phase 1	Completed	Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma	13	China	clinicaltrials.gov
September 24, 2026	NCT07840092	Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma	Tianjin Medical University Cancer Institute and Hospital	Observational	Recruiting	Hepatocellular Carcinoma (HCC)	500	China	clinicaltrials.gov
September 24, 2026	NCT07839767	Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence	The University of Hong Kong	Observational	Recruiting	HCC - Hepatocellular Carcinoma	20	Hong Kong	clinicaltrials.gov
September 24, 2026	NCT07838415	Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical...	Tongji Hospital	Observational	Recruiting	Hepatocellular Carcinoma (HCC), Treatment Response	400	China	clinicaltrials.gov
September 23, 2026	NCT07836712	Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced...	University of Southern California	Phase 2	Not yet recruiting	Advanced Hepatocellular Carcinoma, Advanced Melanoma, Locally Advanced Melanoma, Metastatic Melanoma, Stage III...	46	United States	clinicaltrials.gov
September 23, 2026	NCT07836530	Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma	BeOne Medicines	Phase 3	Not yet recruiting	Hepatocellular Carcinoma, Liver Cancer	492		clinicaltrials.gov
September 23, 2026	NCT07836309	TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602)	Zhongda Hospital	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	596	China	clinicaltrials.gov
September 21, 2026	NCT07832006	Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma	Shunda Du	Phase 2	Recruiting	Hepatocellular Carcinoma (HCC)	30	China	clinicaltrials.gov
September 21, 2026	NCT07829926	Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver Cancer	First Affiliated Hospital of Wenzhou Medical University	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	120		clinicaltrials.gov
September 18, 2026	NCT07827807	PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HCC	Chang Gung Memorial Hospital	Phase 2	Not yet recruiting	Hepatocellular Carcinoma	40		clinicaltrials.gov
September 17, 2026	NCT07825519	Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular...	University Medical Center Ho Chi Minh City (UMC)	Not applicable	Active not recruiting	Transarterial Chemoembolization, TACE(Transcatheter Arterial Chemoembolization), Web-based Intervention, Quality of...	252	Vietnam	clinicaltrials.gov
September 17, 2026	NCT07824583	A Study Evaluating a New Radiation Treatment Workflow (NGDS)	Varian, a Siemens Healthineers Company	Not applicable	Recruiting	Lung Cancer (Diagnosis), Liver Cancer, Adult, Pancreatic Cancer, Thoracic Cancers, Abdominal Cancer	20	United States	clinicaltrials.gov
September 16, 2026	NCT07823348	JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver Cancer	Shanghai Junshi Bioscience Co., Ltd.	Phase 3	Not yet recruiting	Hepatocellular Carcinoma	560	China	clinicaltrials.gov
September 11, 2026	NCT07815054	Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With...	The First Hospital of Jilin University	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	200		clinicaltrials.gov
September 10, 2026	NCT07814014	Real-world Insight Into Systemic Therapies for HCC: Single-center Study	Mansoura University	Observational	Recruiting	HCC - Hepatocellular Carcinoma	1,000	Egypt	clinicaltrials.gov
September 10, 2026	NCT07813572	ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	Phase 3	Not yet recruiting	Hepatocellular Carcinoma	600	China	clinicaltrials.gov
September 10, 2026	NCT07811687	Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function	Northern Jiangsu People's Hospital	Observational	Recruiting	Liver Cirrhosis, HCC - Hepatocellular Carcinoma, Hypersplenism	30	China	clinicaltrials.gov
September 8, 2026	NCT07808164	ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort	Tam Anh Research Institute	Observational	Recruiting	HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial...	162	Vietnam	clinicaltrials.gov
September 8, 2026	NCT07807475	DNP-MRSI of HCC Metabolism to Predict Therapeutic Response	Abramson Cancer Center at Penn Medicine	Observational	Recruiting	Barcelona Clinic Liver Cancer (BCLC) Stage A, B or C HCC, Hepatocellular Carcinoma (HCC)	232	United States	clinicaltrials.gov
September 3, 2026	NCT07801287	Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC	Tianjin Medical University Cancer Institute and Hospital	Phase 2	Recruiting	HCC - Hepatocellular Carcinoma	20	China	clinicaltrials.gov
August 31, 2026	NCT07795437	GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma	Peking University First Hospital	Not applicable	Recruiting	Hepatocellular Carcinoma (HCC)	100	China	clinicaltrials.gov
August 28, 2026	NCT07793695	Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma	Anhui Provincial Hospital	Phase 2	Recruiting	Hepatocellular Carcinoma	60	China	clinicaltrials.gov
August 26, 2026	NCT07786792	Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCC	Shanghai Zhongshan Hospital	Observational	Not yet recruiting	Hepatocellular Carcinoma	400		clinicaltrials.gov
August 24, 2026	NCT07782632	Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma	Anhui Provincial Hospital	Observational	Recruiting	Hepatocellular Carcinoma (HCC)	467	China	clinicaltrials.gov
August 24, 2026	NCT07781176	Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer Patients	Shanghai Zhongshan Hospital	Not applicable	Not yet recruiting	Primary Liver Cancer	132		clinicaltrials.gov
August 21, 2026	NCT07780357	HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B	Beijing Friendship Hospital	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	2,000	China	clinicaltrials.gov
August 20, 2026	NCT07776080	Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2	Recruiting	HCC - Hepatocellular Carcinoma	35	China	clinicaltrials.gov
August 19, 2026	NCT07774247	Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma	CHA University	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	51	South Korea	clinicaltrials.gov
August 17, 2026	NCT07768085	Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT	Shengjing Hospital	Not applicable	Not yet recruiting	Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Hepatic Metastasis, Hepatic Hemangioma, Cyst...	40,000	China	clinicaltrials.gov
August 14, 2026	NCT07764835	Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)	D'Or Institute for Research and Education	Observational	Not yet recruiting	Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Hepatitis B, Metabolic Dysfunction-Associated Steatotic Liver...	300		clinicaltrials.gov
August 12, 2026	NCT07761286	Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 1/2	Not yet recruiting	HCC - Hepatocellular Carcinoma	288	China	clinicaltrials.gov
August 12, 2026	NCT07760012	68Ga-SorB PET/CT Imaging in Patients With Solid Tumors	Peking University Third Hospital	Not applicable	Recruiting	Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer...	50	China	clinicaltrials.gov
August 7, 2026	NCT07751783	Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations	Kaohsiung Medical University Chung-Ho Memorial Hospital	Not applicable	Recruiting	Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer...	150	Taiwan	clinicaltrials.gov
August 6, 2026	NCT07749859	SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2	Not yet recruiting	Advanced Unresectable Hepatocellular Carcinoma	80	China	clinicaltrials.gov
August 6, 2026	NCT07749586	A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors	Arvinas Inc.	Phase 1/2	Recruiting	Advanced Solid Tumor	499	United States	clinicaltrials.gov
August 5, 2026	NCT07748481	Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for...	The First Hospital of Jilin University	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	180		clinicaltrials.gov
August 4, 2026	NCT07745153	Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver Tumors	Southern Medical University, China	Observational	Completed	Liver Neoplasms, Carcinoma, Hepatocellular	120	China	clinicaltrials.gov
July 29, 2026	NCT07734857	Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma	Shanghai Zhongshan Hospital	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	100		clinicaltrials.gov
July 29, 2026	NCT07732686	Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry	University of Oklahoma	Observational	Not yet recruiting	Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon...	2,000	United States	clinicaltrials.gov
July 29, 2026	NCT07732504	AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation	Tongji Hospital	Not applicable	Not yet recruiting	Hepatocellular Carcinoma (HCC)	2,000	China	clinicaltrials.gov
July 27, 2026	NCT07729592	Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome	Sun Yat-sen University	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	44		clinicaltrials.gov
July 27, 2026	NCT07727759	CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure	Minia University	Observational	Recruiting	Post-Hepatectomy Liver Failure, Liver Failure, Liver Neoplasms, Carcinoma, Hepatocellular, Liver Metastases...	1,070	Egypt	clinicaltrials.gov
July 24, 2026	NCT07724951	The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable...	Shanghai Zhongshan Hospital	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	400	China	clinicaltrials.gov
July 21, 2026	NCT07717437	DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver...	Maastricht University Medical Center	Observational	Recruiting	Liver Cancer, Liver Metastases	350	Australia, Austria, Belgium, Canada, Germany, Netherlands, New Zealand, Norway...	clinicaltrials.gov
July 21, 2026	NCT07716345	Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer	Second Affiliated Hospital of Xi'an Jiaotong University	Observational	Not yet recruiting	Hepato Cellular Carcinoma, Intrahepatic Bile Duct Carcinoma, Metastatic Hepatocellular Carcinoma	100		clinicaltrials.gov
July 20, 2026	NCT07714538	Breath Research Narrow Validation for Gastrointestinal Cancer Detection	Imperial College London	Observational	Recruiting	Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal...	1,000	United Kingdom	clinicaltrials.gov
July 20, 2026	NCT07714317	Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in...	Shanghai Zhongshan Hospital	Phase 1/2	Not yet recruiting	Resectable Hepatocellular Carcinoma	90		clinicaltrials.gov
July 20, 2026	NCT07713290	A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma	Beijing Gene Key Life Technology Co., Ltd	Phase 1	Active not recruiting	Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer	6	China	clinicaltrials.gov
July 16, 2026	NCT07709299	Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection	Royan Institute	Early phase 1	Not yet recruiting	Hepatocellular Carcinoma (HCC)	6	Iran	clinicaltrials.gov
July 16, 2026	NCT07707661	Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor	Eastern Hepatobiliary Surgery Hospital	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocellular Carcinoma, Hepatic Hemangioma, Focal Nodular...	350		clinicaltrials.gov
July 15, 2026	NCT07705074	FAPI PET Imaging - An Exploratory Study	Martin Huellner	Phase 1/2	Not yet recruiting	Thyroid Pathology, Head and Neck Cancer (H&N), Sinonasal Tract Tumor, Sarcoidosis, Thyroid Cancer, Breast Cancer...	770	Switzerland	clinicaltrials.gov
July 15, 2026	NCT07704489	San Raffaele Registry on Liver Cancer	IRCCS San Raffaele	Observational	Recruiting	Liver and Intrahepatic Biliary Tract Cancer	4,000	Italy	clinicaltrials.gov
July 15, 2026	NCT07704216	Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer	Second Affiliated Hospital of Xi'an Jiaotong University	Observational	Not yet recruiting	Hepato Cellular Carcinoma, Intrahepatic Bile Duct Carcinoma, Metastatic Hepatocellular Carcinoma	150		clinicaltrials.gov
July 15, 2026	NCT07704203	Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy	Second Affiliated Hospital of Xi'an Jiaotong University	Observational	Not yet recruiting	Hepatic Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocellular Carcinoma, Metastatic Hepatocellular Carcinoma	150		clinicaltrials.gov
July 14, 2026	NCT07703735	Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma	Seoung Hoon Kim	Observational	Enrolling by invitation	Liver Transplantation, Hepatocellular Carcinoma (HCC)	371		clinicaltrials.gov
July 13, 2026	NCT07700082	HCC-MPDS Multimodal Deep Learning Prognostic Model for Resectable HCC	Anhui Provincial Hospital	Observational	Completed	Hepatocellular Carcinoma (HCC)	555	China	clinicaltrials.gov
July 9, 2026	NCT07691762	A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular...	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Phase 3	Not yet recruiting	Hepatocellular Carcinoma	690	China	clinicaltrials.gov
July 9, 2026	NCT07691645	Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome	Xiang-Qian	Phase 2	Not yet recruiting	HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine, ICG (Indocyanine Green), Overall Survival (All-cause...	120	China	clinicaltrials.gov
July 8, 2026	NCT07690683	Patients With Hepatocellular Carcinoma (HCC)	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Not yet recruiting	Hepatocellular Carcinoma, Hepatocellular Cancer, Liver Diseases, Liver Cancer	52	Italy	clinicaltrials.gov
July 8, 2026	NCT07689175	Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	Phase 2	Recruiting	Hepatocellular Carcinoma (HCC)	60	United States	clinicaltrials.gov
July 7, 2026	NCT07687914	A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular Carcinoma	ImmuneOnco Biopharmaceuticals (Shanghai) Inc.	Phase 2	Not yet recruiting	HCC - Hepatocellular Carcinoma	50		clinicaltrials.gov
July 7, 2026	NCT07687758	Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained...	Siriraj Hospital	Observational	Completed	Hepatitis C Virus Infection, Compensated Advanced Chronic Liver Disease, Hepatocellular Carcinoma (HCC)	571	Thailand	clinicaltrials.gov
July 6, 2026	NCT07685548	AI-Driven Tumor Response Evaluation for Solid Tumors	Shanghai Zhongshan Hospital	Observational	Not yet recruiting	Solid Tumor Cancer, Neoplasms, Hepatocellular Carcinoma	6,120		clinicaltrials.gov
July 2, 2026	NCT07682454	Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin	University of California, San Francisco	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC), Liver Cancer, Adult	50	United States	clinicaltrials.gov
July 2, 2026	NCT07681817	Risk Stratification and Proactive Nursing Intervention for Acute Kidney Injury Following Interventional Therapy in Patients With Liver...	Tianjin Medical University Cancer Institute and Hospital	Not applicable	Not yet recruiting	Liver Cancer, Adult	200		clinicaltrials.gov
July 1, 2026	NCT07679061	First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)	Bristol-Myers Squibb	Observational	Recruiting	Unresectable Hepatocellular Carcinoma	200	Japan	clinicaltrials.gov
July 1, 2026	NCT07677774	GPC3-Targeted PET/CT in Hepatocellular Carcinoma	The First Affiliated Hospital of Xiamen University	Not applicable	Recruiting	Hepatocellular Carcinoma (HCC), Glypican-3, GPC3-targeted PET/CT	40	China	clinicaltrials.gov
June 30, 2026	NCT07675187	HCC Risk and Monitoring in Patients With Type 2 Diabetes	National Taiwan University Hospital	Not applicable	Not yet recruiting	Type 2 Diabetes (T2DM), Hepatocellular Carcinoma (HCC)	2,400	Taiwan	clinicaltrials.gov
June 25, 2026	NCT07669727	A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.	Boston Scientific Corporation	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC)	140		clinicaltrials.gov
June 25, 2026	NCT07669597	Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular...	Sohag Oncology Center	Observational	Active not recruiting	Locally Advanced or Metastatic Hepatoceullar Carcinoma	50	Egypt	clinicaltrials.gov
June 25, 2026	NCT07668570	SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma	Hebei Medical University Fourth Hospital	Phase 4	Not yet recruiting	HCC - Hepatocellular Carcinoma	36		clinicaltrials.gov
June 25, 2026	NCT07667608	Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting...	Assiut University	Observational	Not yet recruiting	Cirrhosis of the Liver, Ascites, Pleural Effusion Disorder, Hepatocellular Carcinoma (HCC), Sarcopenia, Diaphragm...	120		clinicaltrials.gov
June 23, 2026	NCT07664007	Effects of EPA Supplementation on Patients With Unresectable Hepatocellular Carcinoma.	Instituto de Investigación Sanitaria Aragón	Not applicable	Completed	Hepatocellular Carcinoma	18	Spain	clinicaltrials.gov
June 23, 2026	NCT07663487	A Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to...	Sirtex Medical	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	78		clinicaltrials.gov
June 22, 2026	NCT07658833	TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Observational	Recruiting	Hepatocellular Carcinoma (HCC)	120	China	clinicaltrials.gov
June 22, 2026	NCT07658586	AI Multimodal Model for Liver Cancer Diagnosis and Prognosis	Guangxi Medical University	Observational	Active not recruiting	Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma (Icc)	600	China	clinicaltrials.gov
June 18, 2026	NCT07658105	Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI	Tianjin Medical University Cancer Institute and Hospital	Phase 2	Active not recruiting	HCC - Hepatocellular Carcinoma	60	China	clinicaltrials.gov
June 18, 2026	NCT07657416	NK521 in the Treatment of Advanced Solid Tumors	Base Therapeutics (Shanghai) Co., Ltd.	Early phase 1	Not yet recruiting	Hepatocellular Carcinoma (HCC), Ovarian Cancer, Malignant Ascites	18	China	clinicaltrials.gov
June 18, 2026	NCT07657273	Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma	Second Affiliated Hospital of Guangzhou Medical University	Phase 2	Not yet recruiting	Hepatocellular Carcinoma	20	China	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Tianjin Medical University Cancer Institute and Hospital	15	September 24, 2026
Shanghai Zhongshan Hospital	14	November 5, 2026
Tongji Hospital	14	September 24, 2026
Sun Yat-sen University	11	July 27, 2026
West China Hospital	10	October 8, 2026
IRCCS Azienda Ospedaliero-Universitaria di Bologna	10	May 22, 2026
Zhongda Hospital	9	September 23, 2026
Fudan University	8	February 17, 2026
Anhui Provincial Hospital	7	August 28, 2026
Peking Union Medical College Hospital	7	May 15, 2026
Nanfang Hospital, Southern Medical University	7	May 4, 2026
Seoul National University Hospital	7	March 17, 2026
The First Hospital of Jilin University	6	September 11, 2026
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	6	July 8, 2026
AstraZeneca	6	June 16, 2026
Assistance Publique - Hôpitaux de Paris	6	June 5, 2026
First Affiliated Hospital, Sun Yat-Sen University	6	May 12, 2026
Beijing Tsinghua Chang Gung Hospital	6	April 20, 2026
National Taiwan University Hospital	5	June 30, 2026
Second Affiliated Hospital of Guangzhou Medical University	5	June 18, 2026

By phase

Phase	New trials	Latest
Observational	194	October 29, 2026
Phase 2	124	November 5, 2026
Not applicable	111	November 9, 2026
Phase 1	46	October 6, 2026
Phase 1/2	29	October 16, 2026
Phase 3	20	October 26, 2026
Phase 4	11	June 25, 2026
Early phase 1	9	July 16, 2026
Phase 2/3	9	March 24, 2026

By country

Country	New trials	Latest
China	239	November 5, 2026
United States	70	November 4, 2026
Italy	31	July 15, 2026
South Korea	28	October 21, 2026
France	23	June 9, 2026
Taiwan	18	August 7, 2026
United Kingdom	14	July 21, 2026
Egypt	13	October 29, 2026
Canada	12	October 26, 2026
Spain	12	October 13, 2026
Australia	12	July 21, 2026
Germany	11	November 9, 2026
Netherlands	9	October 26, 2026
Belgium	8	October 7, 2026
Hong Kong	8	September 24, 2026
Japan	8	July 1, 2026
Poland	7	February 6, 2026
Sweden	6	July 21, 2026
Austria	5	July 21, 2026
Switzerland	5	July 21, 2026
Turkey (Türkiye)	5	June 16, 2026
Thailand	4	July 7, 2026
India	4	February 27, 2026
Vietnam	3	September 17, 2026
Norway	3	July 21, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.